SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avidity ...
eagletribune.com
news
2022-10-15 03:51:21

NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. ('Avidity' or the 'Company') (NASDAQ: RNA). Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Avidity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action]On or around June 12, 2020, Avidity conducted its initial public offering ('IPO'), selling 14.
